Virtu Financial’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-514
Closed -$6K 1863
2024
Q4
$6K Buy
+514
New +$6.69K ﹤0.01% 1425
2024
Q2
Sell
-1,271
Closed -$34K 1745
2024
Q1
$34K Sell
1,271
-2,114
-62% -$50.9K ﹤0.01% 1086
2023
Q4
$68K Buy
+3,385
New +$46.7K 0.01% 1120

Other funds holding PASG

Virtu Financial's PASG Position: Q1 2025 in Review

Virtu Financial sold out of Passage Bio (PASG) in Q1 2025, closing a stake of 514 shares — an estimated $6K sold.

Virtu Financial first reported a position in PASG in Q4 2023 and held it in 3 quarters. The position peaked at $68K in Q4 2023. 41 funds tracked by Wall St. Rank hold PASG as of Q1 2025.

  • Virtu Financial reported no remaining Passage Bio position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 514 Passage Bio shares in Q1 2025, an estimated $6K.
  • Virtu Financial first reported a position in Passage Bio in Q4 2023 and held it in 3 quarters.
  • Virtu Financial's Passage Bio position peaked at $68K in Q4 2023.
  • 41 funds tracked by Wall St. Rank held Passage Bio as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.